90 per cent cheaper cancer treatment gets nod, to be offered in 20 hospitals

Under the therapy, blood is taken from the patient and the T-cells, which help the immune system fight back diseases, are genetically modified or re-engineered by adding lentiviral vectors. These genetically modified cells are then injected back into the patient where they attack and kill cancer cells.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/zZoy94g
via